Clinical Trial Update: A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating standard treatment with or without apatinib in extensive-stage small cell lung cancer; the document lists the status as UNKNOWN and d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Qingdao University | Conditions: Progression Free Survival | Phase 3 | Status: UNKNOWN